Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-19
2000-04-18
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142392, 514255, 514333, 514340, 514341, 514343, 514359, 514424, 514425, 514427, 514428, 514408, A61K 31535, A01N 4360, A01N 4340, A01N 4364, A01N 4336
Patent
active
060515732
ABSTRACT:
Compositions of non-steroidal glucocorticoid antagonists for treating GLC1A glaucoma and methods for their use are disclosed.
REFERENCES:
patent: 4296206 (1981-10-01), Simons, Jr.
patent: 4395404 (1983-07-01), Low et al.
patent: 4861580 (1989-08-01), Janoff et al.
patent: 5606043 (1997-02-01), Nguyen et al.
"Ketoconazole Binds to Glucocorticoid Receptors and Exhibits Glucocorticoid Antagonist Activity in Cultured Cells", Loose et al., J. Clin. Invest., vol. 72, 1983, pp. 404-408.
"Steroids, Ocular Hypertension, and Glaucoma", Abbot F. Clark, Ph.D., Journal of Glaucoma, vol. 4, Oct. 1995, pp. 354-369.
Sommer A, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch. Ophthalmol. 109:1090-1095, (1991).
Sheffield, et al., "Genetic Linkage of Familial Open Angle Glaucoma to Chromosome 1q21-q31," Nature Genetics, 4:47-50 (1993).
Sarfarazi, et al., "Assignment of a Locus (GLC3A) for Primary Congenital Glaucoma (Buphthalmos) to 2p21 and Evidence for Genetic Heterogeneity," Genomics, 30:171-177 (1995).
Akarsu, et al., "A Second Locus (GLC3B) for Primary Congenital Glaucoma (Buphthalmos) Maps to the 1p36 Region," Human Molecular Genetics, 5(8):1199-1203 (1996).
Stoilova, et al., "Localization of a Locus (GLC1B) for Adult-Onset Primary Open Angle Glaucoma to the 2cen-q13 Region," Genomics, 36:142-150 (1996).
Wirtz, et al., "Mapping a Gene for Adult-Onset Primary Open-Angle Glaucoma to Chromosome 3q," Am. J. Hum. Genet., 60:296-304 (1997).
Andersen, et al., "A Gene Responsible for the Pigment Dispersion Syndrome Maps to Chromosome 7q35-q36," Arch. Ophthalmol., 115:384-388 (1997).
Richards, et al., "Mapping of a Gene for Autosomal Dominant Juvenile-Onset Open-Angle Glaucoma to Chromsome 1q," Am. J. Hum. Genet., 54:62-70 (1994).
Morissette, et al., "A Common Gene for Juvenile and Adult-Onset Primary Open-Angle Glaucomas Confined on Chromosome 1q," Am. J. Hum. Genet., 56:1431-1442 (1995).
Wiggs, et al., "Genetic Linkage of Autosomal Dominant Juvenile Glaucoma to 1q21-q31 in Three Affected Pedigrees," Genomics, 21:299-303 (1994).
Meyer, et al., "Age-Dependent Penetrance and Mapping of the Locus for Juvenile and Early-Onset Open-Angle Glaucoma on Chromosome 1q (GLC1A) in a Frence Family," Hum. Genet., 98:567-571 (1996).
Graff, et al., "Confirmation of Linkage to 1q21-31 in a Danish Autosomal Dominant Juvenile-Onset Glaucoma Family and Evidence of Genetic Heterogeneity," Hum. Genet., 96:285-289 (1995).
Stone, et al., "Identification of a Gene That Causes Primary Open Angle Glaucoma," Science, 275:668-670 (1997).
Polansky, et al., "Eicosanoid Production and Glucocorticoid Regulatory Mechanisms in Cultured Human Trabecular Meshwork Cells," The Ocular Effects of Prostaglandins and Other Eicosanoids, pp. 113-138 (1989).
Polansky, et al., "In Vitro Correlates of Glucocorticoid Effects on Intraocular Pressure," Glaucoma Update IV (1991).
Polansky, et al., "Cellular Pharmacology and Molecular Biology of the Trabecular Meshwork Inducible Glucocorticoid Response Gene Product," Ophthalmologica, 211:126-139 (1997).
Ortego, et al., "Cloning and Characterization of Subtracted cDNAs from a Human Ciliary Body Library Encoding TIGR, a Protein Involved in Juvenile Open Angle Glaucoma with Homology to Myosin and Olfactomedin," FEBS Letters, 413:349-353 (1997).
(Kubota, et al., "A Novel Myosin-like Protein (Myocilin) Expressed in the Connecting Cilium of the Photoreceptor: Molecular Cloning, Tissue Expression, and Chromosomal Mapping," Genomics, 41:360-369 (1997).
Sunden, et al., "Fine Mapping of the Autosomal Dominant Juvenile Open Angle Glaucoma (GLC1A) Region and Evaluation of Candidate Genes," Genome Research, 6:862-869 (1996).
Adam, et al., "Recurrent Mutations in a Single Exon Encoding the Evolutionarily Conserved Olfactomedin-Homology Domain of TIGR in Familial Open-Angle Glaucoma," Human Molecular Genetics, 6(12):2091-2097 (1997).
Kass, et al., "Corticosteroid-Induced Glaucoma, In Ritch, R., Shields, M. B., Krupin, T. (eds.)," The Glaucomas, The C. V. Mosby Company, St. Louis, MO, pp. 1161-1168 (1989).
De Santis, et al., Dexamethasone-Induction of Ocular Hypertension in the Primate, ARVO Abstracts. Invest. Ophthalmol. Vis. Sci., 31(Suppl.):99 (1990).
Knepper, et al., "Intraocular Pressure and Glycosaminoglycan Distribution in the Rabbit Eye: Effect of Age and Dexamethasone," Exp. Eye Res., 27:567-575 (1978).
Francois, et al., Ultrastructural and Morphometric Study of Corticosteroid Glaucoma in Rabbits, Ophthalmic Res., 16:168-178 (1984).
Lorenzetti, O. J., "Effects of Corticosteroids on Ocular Dynamics in Rabbits," J. Pharmacol. Exp. Therap., 175:763-772 (1970).
Zhan, et al., "Steroid Glaucoma: Corticosteroid-Induced Ocular Hypertension in Cats," Exp. Eye Res., 54:211-218 (1992).
Rozsival, et al., "Aqueous Humour and Plasma Cortisol Levels in Glaucoma and Cataract Patients," Current Eye Research, 1:391-396 (1981).
Ray, et al., "Plasma Cortisol in Glaucoma," Ann. Ophthalmol., 9:1151-1154 (1977).
Schwartz, et al., "Increased Plasma Free Cortisol in Ocular Hypertension and Open Angle Glaucoma," Arch. Ophthalmol., 105:1060-1065 (1987).
Wilson, et al., Dexamethasone Induced Ultrastructural Changes in Cultured Human Trabecular Meshwork Cells, Cur. Eye Res., 12:783-793 (1993).
Clark, et al., "Glucocorticoid-Induced Formation of Cross-Linked Actin Networks in Cultured Human Trabecular Meshwork Cells," Invest. Ophthalmol. Vis. Sci., 35:281-294 (1994).
Loose, et al., "Ketoconazole Binds to Glucocorticoid Receptors and Exhibits Glucocorticoid Antagonist Activity in Cultured Cells," J. Clin. Invest., 72:404-408 (1983).
Alcon Laboratories Inc.
Dees Jos,e G.
Pryor Alton
Yeager Sally
LandOfFree
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of GLC1A glaucoma with non-steroidal glucocorticoid an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of GLC1A glaucoma with non-steroidal glucocorticoid an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336550